OB/GYN & Women’s Health – Page 4

Evaluating Selenium Supplementation in Gestational Diabetes Mellitus: Insights from a Systematic Review and Meta-Analysis

By MedXY 10/12/2025

Selenium supplementation at 200 µg/d may reduce fasting plasma glucose and newborn hyperbilirubinemia risk in gestational diabetes without significantly altering lipid profiles, highlighting potential but limited benefits requiring further research.

news OB/GYN & Women's Health Urology

Vaginal Lasers in Stress Urinary Incontinence: Evaluating Efficacy and Safety through an Abridged Cochrane Review

By MedXY 10/12/2025

This article reviews current evidence from a Cochrane systematic review on vaginal laser therapy for stress urinary incontinence in women, highlighting uncertain efficacy and safety profiles compared to sham and other treatments.

Diabetes & Endocrinology news OB/GYN & Women's Health Specialties

Evaluating Myo-Inositol Supplementation for Preventing Pregnancy Complications in PCOS: Insights from a Robust Randomized Trial

By MedXY 10/10/2025

A large randomized clinical trial found that myo-inositol supplementation during pregnancy in individuals with PCOS did not significantly reduce rates of gestational diabetes, preeclampsia, or preterm birth compared to placebo.

news OB/GYN & Women's Health Oncology Radiology Specialties

Impact of Immediate Past Mammography Participation on Outcomes of Screen-Detected Breast Cancer

By MedXY 10/04/2025

This cohort study reveals that women with screen-detected breast cancer who missed the immediate prior mammography screening have larger tumors, more advanced disease, and worse breast cancer-specific survival, suggesting delayed detection and poorer prognosis.

Clinical Updates OB/GYN & Women's Health Public Health Specialties

Cost-Effectiveness of Mailed HPV Self-Testing Kits for Cervical Cancer Screening Across Diverse Screening Histories

By MedXY 10/01/2025

Economic evaluation shows direct mailing of HPV self-sampling kits improves cervical cancer screening completion and is cost-effective among varied screening history groups in a US healthcare system, with budget benefits over time.

Allergy & Immunology Clinical Updates news OB/GYN & Women's Health Specialties

Menopause and Multiple Sclerosis: Evaluating the Impact on Disability Progression

By MedXY 09/29/2025

A comprehensive analysis reveals that menopause does not significantly alter the risk of disability progression in women with relapse-onset multiple sclerosis, underscoring the complexity of reproductive aging's role in disease trajectory.

OB/GYN & Women's Health Oncology Specialties

Seventeen Years On: Robust Population-Level Effectiveness and Herd Protection from HPV Vaccination in High-Risk Young Women

By MedXY 09/29/2025

Seventeen years after HPV vaccine introduction, substantial reductions in vaccine-type HPV prevalence confirm strong effectiveness and herd protection among vaccinated and unvaccinated sexually experienced adolescent girls and young women at high risk for HPV.

Clinical Updates OB/GYN & Women's Health Pediatrics Specialties

Antenatal Betamethasone Reduces Respiratory Morbidity in Late Preterm Twins: Landmark Randomized Trial

By MedXY 09/28/2025

This multicenter randomized trial demonstrates that antenatal betamethasone significantly lowers severe respiratory morbidity in late preterm twin neonates, offering evidence-based guidance for managing twin pregnancies at imminent preterm delivery.

OB/GYN & Women's Health Oncology Specialties

Evolving Trends and Economic Implications of Breast Cancer Screening in Older US Women: Navigating Value and Cost

By MedXY 09/28/2025

Breast cancer screening among older US women shows stable use but rising costs driven by low-value technologies; optimizing screening strategies could enhance value and reduce expenditure.

Clinical Updates news OB/GYN & Women's Health Oncology

Chemoradiotherapy Enhances Long-Term Survival in High-Risk Endometrial Cancer

By MedXY 09/25/2025

The PORTEC-3 trial demonstrates that adding platinum-based chemotherapy to pelvic radiotherapy significantly improves 10-year overall and recurrence-free survival in high-risk endometrial cancer, especially in patients with p53 abnormal tumors, emphasizing the importance of molecular profiling.

Allergy & Immunology Clinical Updates OB/GYN & Women's Health

Pregnancy and Disease Outcomes in Women with Moderate to Severe Multiple Sclerosis Disability

By MedXY 09/24/2025

This study evaluates how pregnancy affects relapse rates and long-term disability in women with moderate to severe multiple sclerosis (MS), showing pregnancy reduces relapse during gestation without worsening long-term disability progression.

news OB/GYN & Women's Health Oncology Specialties

Impact of Treatment Recommendation and Receipt on Survival in Older Women with Early-Stage Cervical Cancer

By MedXY 09/24/2025

This study reveals that among women aged 65 and older with early-stage cervical cancer, those who receive recommended treatment—surgery and/or radiotherapy—exhibit significantly higher survival rates, emphasizing the need to overcome treatment barriers in this population.

Clinical Updates Neurology news OB/GYN & Women's Health Specialties

Sleep Disorders in Pregnancy: Unveiling Their Impact on Ischemic Placental Disease and Severe Morbidity

By MedXY 09/24/2025

Pregnant individuals with insomnia or obstructive sleep apnea face significantly increased risks of ischemic placental disease, severe maternal morbidity, and preterm birth, highlighting the critical need for early detection and intervention.

Clinical Updates OB/GYN & Women's Health

Influence of Physician Peer Networks on the Adoption of Opportunistic Salpingectomy for Ovarian Cancer Prevention

By MedXY 09/23/2025

Physician peer influence significantly increases the adoption of opportunistic salpingectomy during postpartum and interval tubal sterilizations, enhancing ovarian cancer prevention.

Clinical Updates Neurology OB/GYN & Women's Health

Intranasal Mesenchymal Stromal Cells for Perinatal Arterial Stroke: Promising Safety and Improved Neurodevelopment at Two Years

By MedXY 09/22/2025

The PASSIoN study shows that intranasally administered allogeneic mesenchymal stromal cells in neonates with perinatal arterial ischemic stroke are safe up to two years and suggest better motor outcomes compared to untreated cohorts.

Clinical Updates Internal Medicine OB/GYN & Women's Health Specialties

Evaluating Low-Dose Aspirin for Postpartum Venous Thromboembolism Prevention: Insights from the Pilot PARTUM Trial

By MedXY 09/20/2025

The pilot PARTUM trial demonstrates the feasibility of a large-scale multi-national randomized study assessing low-dose aspirin versus placebo for postpartum venous thromboembolism prevention in moderate-risk individuals, supporting further investigation.

Clinical Updates news OB/GYN & Women's Health Specialties

Certolizumab Pegol Shows Promise in Reducing Adverse Pregnancy Outcomes in High-Risk APS Patients: Insights from the IMPACT Trial

By MedXY 09/19/2025

The IMPACT trial demonstrates that adding certolizumab pegol to standard therapy reduces placenta-mediated adverse pregnancy outcomes in women with antiphospholipid syndrome and lupus anticoagulant, with favorable safety and neonatal outcomes.

Clinical Updates news OB/GYN & Women's Health Specialties

Aspirin for Delaying Preterm Birth in High-Risk Preterm Pre-eclampsia Pregnancies: Insights from a Multicenter Randomized Trial in Asia

By MedXY 09/19/2025

Early low-dose aspirin reduces early preterm birth risk and delays timing of delivery in women at high risk for preterm pre-eclampsia, with significant benefits in iatrogenic preterm births and small-for-gestational-age pregnancies.

Clinical Updates news OB/GYN & Women's Health

Optimizing Nifedipine GITS Dosing in Severe Preeclampsia: Daily 60 mg versus 30 mg BID – Evidence from a Randomized Controlled Trial

By MedXY 09/19/2025

This RCT compares nifedipine GITS 30 mg twice daily versus 60 mg once daily in severe preeclampsia, finding similar blood pressure control but fewer emergent treatments with twice-daily dosing, informing safer antihypertensive strategies in pregnancy.

Medical News news OB/GYN & Women's Health Specialties

Coenzyme Q10: A Natural Ally Against Ovarian Aging and a Booster for Female Fertility

By MedXY 09/18/2025

Scientific evidence highlights coenzyme Q10 supplementation as a promising intervention to combat ovarian aging, improve oocyte quality, and enhance female fertility, especially for women over 35 or with compromised ovarian reserve.